---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-22-155023"
form_type: "8-K"
ticker: "KLRS"
cik: "0001754068"
company_name: "Kalaris Therapeutics, Inc."
filed_at: "2022-05-19T23:59:59+00:00"
generated_at: "2026-06-25T09:21:12.374830+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "high"
source: SEC EDGAR
---

# AlloVir stockholders elect Sinha and Brenner as Class II directors; ratify Deloitte

## Summary
- Vikas Sinha elected with 47,229,880 for, 4,036,755 withhold, 10,745,678 broker non-votes.
- Malcolm Brenner elected with 48,449,496 for, 2,817,139 withhold, 10,745,678 broker non-votes.
- Ratification of Deloitte & Touche as auditor approved: 61,754,011 for, 250,317 against, 7,985 abstain.

## SEC filing metadata
- accession: 0001193125-22-155023
- form_type: 8-K
- ticker: KLRS
- cik: 0001754068
- company_name: Kalaris Therapeutics, Inc.
- filed_at: 2022-05-19T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1754068/000119312522155023/0001193125-22-155023-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1754068/000119312522155023/d346922d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-22-155023
- JSON: https://secwatch.observer/filing/0001193125-22-155023.json
- Plain text: https://secwatch.observer/filing/0001193125-22-155023.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.